Progesterone Support Protocols Compared
Progesterone support is one of the most universal elements of an IVF cycle, yet the delivery method varies enormously between clinics, countries, and individual protocols. Some clinics use intramuscular injections exclusively. Others have shifted entirely to vaginal suppositories. A growing number offer subcutaneous formulations. Each has trade-offs in absorption, convenience, side effects, and patient experience.
Why Progesterone Matters in IVF
In a natural conception cycle, the corpus luteum (the structure left behind after ovulation) produces progesterone to prepare and maintain the endometrial lining for implantation. In IVF, the egg retrieval procedure removes the follicular cells that would form the corpus luteum, and the medications used to prevent premature ovulation further suppress natural progesterone production.
In medicated frozen embryo transfer (FET) cycles, there is no ovulation at all, and therefore no corpus luteum. The entire progesterone supply is exogenous. Without it, the lining would shed and the transfer would fail.
Route-by-Route Comparison
| Route | Common Forms | Serum Levels | Uterine Delivery | Key Drawback |
|---|---|---|---|---|
| Intramuscular (PIO) | Progesterone in oil (sesame, olive, ethyl oleate) | High, consistent | Indirect (via bloodstream) | Daily injections; soreness, lumps, allergic reactions to oil |
| Vaginal | Endometrin, Crinone, Utrogestan, compounded | Lower serum, high tissue | Direct (first-uterine-pass effect) | Discharge, irritation, multiple daily insertions |
| Subcutaneous | Prolutex (aqueous progesterone) | Moderate | Indirect | Not available everywhere; injection site reactions |
| Oral | Prometrium (micronized) | Low (high first-pass liver metabolism) | Indirect | Lowest bioavailability; drowsiness; rarely used alone for IVF |
| Rectal | Cyclogest suppositories | Moderate | Indirect | Limited adoption; less studied |
What the Head-to-Head Trials Show
Several large randomized trials have compared PIO to vaginal progesterone. The LOTUS I and II trials, the largest to date, found no significant difference in ongoing pregnancy rates between intramuscular PIO and vaginal Endometrin in fresh IVF cycles. Similar findings have been replicated in frozen embryo transfer protocols.
The key nuance is the serum level threshold. Because vaginal progesterone delivers the drug directly to the uterus through a "first-uterine-pass" effect, serum levels are often lower than with PIO even when tissue levels are adequate. This can cause anxiety for patients (and some clinicians) who monitor serum progesterone as a reassurance metric.
Patient Experience and Adherence
Compliance matters. The best progesterone protocol is one the patient can sustain for 8 to 12 weeks without burnout. PIO injections require a partner or self-injection skill, and the cumulative soreness from daily intramuscular shots for weeks is a genuine quality-of-life issue. Vaginal progesterone avoids needles but requires 2 to 3 insertions per day and produces persistent discharge.
Some clinics offer combination protocols: PIO every other day or every third day, supplemented with vaginal progesterone on off-days. This reduces injection burden while maintaining higher serum levels. The evidence base for combination protocols is smaller but growing.
Subcutaneous Progesterone: The Newer Option
Subcutaneous aqueous progesterone (Prolutex) is gaining adoption in Europe and Latin America. It uses a thinner needle and water-based formulation, making injections less painful and eliminating the oil-related complications of PIO. Randomized data suggests comparable efficacy to PIO and vaginal routes.
Availability varies by country. In the US, Prolutex is not widely available. In Colombia and much of Europe, it is a standard option.
Choosing Your Protocol
The choice usually comes down to a conversation with your clinic that weighs:
- Your clinic's standard protocol and their experience with each route
- Your tolerance for injections versus vaginal administration
- Whether you have had a suboptimal response to one route in a prior cycle
- Availability and cost of formulations in your country
- Whether your clinic monitors serum progesterone and what thresholds they use
Frequently Asked Questions
Why is progesterone needed after embryo transfer?
During a natural cycle, the corpus luteum produces progesterone to support the uterine lining. In IVF, especially in frozen embryo transfer cycles, the trigger medication and egg retrieval disrupt the corpus luteum's function (or there is no corpus luteum at all in medicated FET). Supplemental progesterone maintains the lining until the placenta takes over at roughly 8 to 10 weeks.
Are PIO injections better than vaginal progesterone?
Large randomized trials have shown comparable pregnancy and live birth rates between intramuscular PIO and vaginal progesterone in most patients. PIO achieves higher serum levels, which some clinicians prefer for reassurance, but vaginal routes deliver progesterone more directly to the uterus.
Can I use oral progesterone instead of injections?
Oral micronized progesterone (Prometrium) has been studied as a component of luteal support, but it has lower bioavailability than vaginal or intramuscular routes. It is sometimes used in combination with vaginal progesterone rather than as a standalone.
How long do I need to take progesterone after transfer?
Typically through the end of the first trimester (10 to 12 weeks), at which point the placenta has usually assumed progesterone production. Your clinic will have a specific weaning protocol.
What if my progesterone level drops during the luteal phase?
A drop in serum progesterone may prompt your clinic to increase the dose, add a second route (e.g., add PIO to vaginal), or switch formulations. The threshold that triggers concern varies by clinic and by the route of administration being used.
Ready for the Next Step?
Talk to a fertility coordinator who can walk you through protocol options, cost structures, and clinic comparisons. No pressure, no sponsorships.
Start a Conversation on WhatsApp